Methyl 3-fluoro-4-nitrobenzoate

We are Methyl 3-fluoro-4-nitrobenzoate CAS:185629-31-6 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:Methyl 3-fluoro-4-nitrobenzoate
CAS.NO:185629-31-6
Synonyms:Methyl 3-fluoro-4-nitrobenzoate
3-Fluoro-4-nitrobenzoic acid methyl ester
Methyl 3-Fluoro-4-nitrobenzenecarboxylate
 
Physical and Chemical Properties:
Density 1.4±0.1 g/cm3
Boiling Point 314.6±32.0 °C at 760 mmHg
Melting Point 59-61ºC
Molecular Formula C8H6FNO4
Molecular Weight 199.136
Flash Point 144.1±25.1 °C
Vapour Pressure 0.0±0.7 mmHg at 25°C
Index of Refraction 1.534
 
Specification:
Appearance:Yellow powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Organic synthesis.

Methyl 3-fluoro-4-nitrobenzoate


Related News: In the context of increasingly tight global productive capacity cooperation in the pharmaceutical industry, some multinational pharmaceutical companies have chosen to abandon their original full industrial chain model and shift their focus to market operations. R & D, clinical, and production links reduce costs through outsourcing. Patented APIs came into being.6-cloro-3-metiluracilo CAS:4318-56-3 In the context of increasingly tight global productive capacity cooperation in the pharmaceutical industry, some multinational pharmaceutical companies have chosen to abandon their original full industrial chain model and shift their focus to market operations. R & D, clinical, and production links reduce costs through outsourcing. Patented APIs came into being.[dimethylamino-(1-oxidopyridin-1-ium-2-yl)sulfanylmethylidene]-dimethylazanium,hexafluorophosphate CAS:212333-72-7 Multinational drugmakers usually cut the price of drugs when they go off-patent and face competition from generic versions, but such price drops were slow to happen in China, partially because many local drugmakers were unable to develop high-quality generic drugs to compete with off-patent branded drugs.3-Formylphenylboronic acid Multinational drugmakers usually cut the price of drugs when they go off-patent and face competition from generic versions, but such price drops were slow to happen in China, partially because many local drugmakers were unable to develop high-quality generic drugs to compete with off-patent branded drugs.On Friday, US Health and Human Services Secretary Alex Azar declared the 2019 novel coronavirus a public health emergency and ordered any US citizens returning from the center of the outbreak in China to be quarantined for two weeks as a precaution.

Related Products
Product Name
Antioxidant GM View Details
Laurocapram View Details
Potassium bisulfate View Details
2,4-Dichloro-5-Isopropoxyaniline manufacturer 4,5,6,7-tetrahydrothieno[3,2-c]pyridine,hydrochloride manufacturer 4-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine-1-carboxylic acid tert-butyl ester manufacturer 1,1-diphenyl-4-piperidin-1-ylbutan-1-ol,hydrochloride Cas:3254-89-5 manufacturer 2,2-Diethoxyacetophenone manufacturer